Evenity®▼ Europe In Europe, EVENITY® (romosozumab) is indicated in the treatment of severe osteoporosis in postmenopausal women at high risk of fracture. ▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. Prescribing information Europe EVENITY® SmPC Europe (Sourced from www.ema.europa.eu) Related websites EVENITY® product website (in German) EVENITY® product website (UK) Osteoporosis website (in Spanish)
